TITLE

Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis

AUTHOR(S)
Ling Lin; Zhi-Tao Gu; Wen-Hu Chen; Ke-Jian Cao
PUB. DATE
October 2015
SOURCE
Diagnostic Pathology;10/9/2015, Vol. 10 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Emerging evidences indicate that dysregulated long non-coding RNAs (lncRNAs) are implicated in cancer tumorigenesis and progression. LncRNA ANRIL has been shown to promote the progression of gastric cancer. However, the role of lncRNA ANRIL in human non-small cell lung cancer (NSCLC) remains unclear. Methods: Expression of lncRNA ANRIL was analyzed in 87 NSCLC tissues and three lung cancer cell lines by quantitative real-time PCR (qRT-PCR). The correlation of lncRNA ANRIL with clinicopathological features and prognosis was analyzed. Suppression of lncRNA ANRIL using siRNA treatment was performed in order to explore its role in tumor progression. Results: The expression level of lncRNA ANRIL was higher in NSCLC tissues and lung cancer cells than in adjacent non-tumor tissues and normal human bronchial epithelial cells. Higher expression of lncRNA ANRIL in NSCLC tissues was associated with higher TNM stage and advanced lymph node metastasis. Patients with high lncRNA ANRIL expression had poorer overall survival compared with low lncRNA ANRIL group. Univariate and multivariate analyses suggested that high expression of lncRNA ANRIL was an independent poor prognostic indicator for NSCLC patients. Moreover, knockdown of lncRNA ANRIL expression could inhibit lung cancer cell proliferation, migration and invasion in vitro. Conclusions: Our results suggested that lncRNA ANRIL was a potential biomarker for NSCLC prognosis, and the dysregulation of lncRNA ANRIL may play an important role in NSCLC progression.
ACCESSION #
110235188

 

Related Articles

  • MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression By Targeting PDK1/PI3K/AKT Pathway. Wei, Yingying; Liao, Yuanfan; Deng, Yu; Zu, Yukun; Zhao, Bo; Li, Fan // OncoTargets & Therapy;Oct2019, Vol. 12, p9005 

    aim of the study was to study the role of dysregulated expression of a microRNA (miRNA), miR-503, in non-small-cell lung cancer (NSCLC) and investigate the underlying mechanism. Methods: Quantitative real-time PCR (qRT-PCR) and in situ hybridization staining (ISH) were used to evaluate the...

  • NSCLC, early stage.  // Annals of Oncology;2016 Supplement, Vol. 27, pvi407 

    No abstract available.

  • NSCLC, locally advanced.  // Annals of Oncology;2016 Supplement, Vol. 27, pvi411 

    No abstract available.

  • NSCLC, metastatic.  // Annals of Oncology;2016 Supplement, Vol. 27, pvi416 

    No abstract available.

  • NSCLC, early stage.  // Annals of Oncology;2016 Supplement, Vol. 27, pix134 

    No abstract available.

  • NSCLC, locally advanced.  // Annals of Oncology;2016 Supplement, Vol. 27, pix136 

    No abstract available.

  • NSCLC, metastatic.  // Annals of Oncology;2016 Supplement, Vol. 27, pix139 

    No abstract available.

  • N2 involvement in lung cancer: the Danaïdes' barrel. Riquet, Marc; Arame, Alex; Fabrea, Elizabeth // European Journal of Cardio-Thoracic Surgery;Jul2015, Vol. 48 Issue 1, p176 

    A letter to the editor is presented in response to the article "Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved," by T....

  • CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer. Paulsen, Erna-Elise; Kilvaer, Thomas; Rakaee Khanehkenari, Mehrdad; Johansen Maurseth, Ramona; Al-Saad, Samer; Hald, Sigurd M.; Al-Shibli, Khalid; Andersen, Sigve; Richardsen, Elin; Busund, Lill-Tove; Bremnes, Roy; Donnem, Tom // Neoplasia;Nov2015, Vol. 17 Issue 11, p839 

    Tumor-infiltrating lymphocytes (TILs) are vital in limiting cancer progression andmay supplement the TNM classification. CD45RO+ memory TILs showmajor prognostic impact in variousmalignancies but have not been extensively explored in non-small cell lung cancer (NSCLC). In this study, we aimed to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics